$MDWK
MDWerks, Inc. Stock $mdwk

$mdwk Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000149315224045414 Filed on November 14, 2024

Income Statement

Concept	2024 Q4	2024 Q3	2023 Q4
Revenue		$1.059M	$104.1K
YoY Change
Cost Of Revenue		$325.8K	$28.55K
YoY Change
Gross Profit		$732.9K	$75.52K
YoY Change
Gross Profit Margin		69.22%	72.57%
Selling, General & Admin		$511.0K	$278.3K
YoY Change		295.7%	254.92%
% of Gross Profit		69.72%	368.55%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization		$61.07K	$15.13K
YoY Change		16864.17%
% of Gross Profit		8.33%	20.03%
Operating Expenses		$569.9K	$293.5K
YoY Change		341.36%	274.22%
Operating Profit		$162.9K	-$217.9K
YoY Change		-226.17%
Interest Expense		-$7.810K	-$550.00
YoY Change		-284.55%
% of Operating Profit		-4.79%
Other Income/Expense, Net		-$5.906K	$2.530K
YoY Change		-103.59%
Pretax Income		$157.0K	-$216.0K
YoY Change		342.43%	175.39%
Income Tax
% Of Pretax Income
Net Earnings		$157.0K	-$216.0K
YoY Change		342.43%	175.39%
Net Earnings / Revenue		14.83%	-207.51%
Basic Earnings Per Share		$0.00
Diluted Earnings Per Share		$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	203.7M shares	201.3M shares	127.5M shares
Diluted Shares Outstanding		201.1M shares

Balance Sheet

Concept	2024 Q3	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$62.48K	$115.1K
YoY Change	-62.37%	385.29%
Cash & Equivalents	$62.48K	$115.1K
Short-Term Investments
Other Short-Term Assets	$16.15K	$28.63K
YoY Change
Inventory	$188.6K	$201.2K
Prepaid Expenses		$28.63K
Receivables	$209.2K	$106.7K
Other Receivables	$103.2K	$97.54K
Total Short-Term Assets	$579.7K	$549.2K
YoY Change	140.49%	2215.42%
LONG-TERM ASSETS
Property, Plant & Equipment	$648.5K	$496.9K
YoY Change	948.43%
Goodwill	$466.6K	$466.6K
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$16.01K
YoY Change
Total Long-Term Assets	$2.715M	$2.684M
YoY Change	1445.22%	-11414.72%
TOTAL ASSETS
Total Short-Term Assets	$579.7K	$549.2K
Total Long-Term Assets	$2.715M	$2.684M
Total Assets	$3.295M	$3.233M
YoY Change	690.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$760.6K	$668.8K
YoY Change	11354.22%	1839.64%
Accrued Expenses	$316.5K	$249.2K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change	-100.0%
Long-Term Debt Due	$265.0K	$96.40K
YoY Change
Total Short-Term Liabilities	$1.342M	$1.067M
YoY Change	538.64%	733.19%
LONG-TERM LIABILITIES
Long-Term Debt	$261.0K	$92.83K
YoY Change
Other Long-Term Liabilities	$786.2K	$912.9K
YoY Change
Total Long-Term Liabilities	$1.047M	$1.006M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.342M	$1.067M
Total Long-Term Liabilities	$1.047M	$1.006M
Total Liabilities	$2.389M	$2.073M
YoY Change	1036.94%	1518.47%
SHAREHOLDERS EQUITY
Retained Earnings	-$1.649M	-$739.4K
YoY Change	215.01%	71.66%
Common Stock	$202.0K	$198.7K
YoY Change	58.48%	62.54%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$905.7K	$1.160M
YoY Change
Total Liabilities & Shareholders Equity	$3.295M	$3.233M
YoY Change	690.6%

Cashflow Statement

Concept	2024 Q3	2023 Q4
OPERATING ACTIVITIES
Net Income	$157.0K	-$216.0K
YoY Change	342.43%	175.39%
Depreciation, Depletion And Amortization	$61.07K	$15.13K
YoY Change	16864.17%
Cash From Operating Activities	-$204.3K	-$253.0K
YoY Change	58.68%	363.74%
INVESTING ACTIVITIES
Capital Expenditures	-$1.830K	$0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities		$121.5K
YoY Change
Cash From Investing Activities	$1.830K	$121.5K
YoY Change	-92.68%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	217.4K	80.50K
YoY Change	-17.94%	47.57%
NET CHANGE
Cash From Operating Activities	-204.3K	-253.0K
Cash From Investing Activities	1.830K	121.5K
Cash From Financing Activities	217.4K	80.50K
Net Change In Cash	14.84K	-50.93K
YoY Change	-90.79%
FREE CASH FLOW
Cash From Operating Activities	-$204.3K	-$253.0K
Capital Expenditures	-$1.830K	$0.00
Free Cash Flow	-$202.5K	-$253.0K
YoY Change	57.26%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1648868	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	905737	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3294954	usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Central Index Key EntityCentralIndexKey	0001295514
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Registrant Name EntityRegistrantName	MDwerks, Inc.
	dei	Entity File Number EntityFileNumber	000-56299
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	33-1095411
	dei	Entity Address Address Line1 EntityAddressAddressLine1	411 Walnut Street
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q3	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	103233	usd
CY2023Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	97533	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	209200	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	106734	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	188630	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	201207	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	579687	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	549217	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	168733	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	10787	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	648519	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	496890	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	46643	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	4339	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	572857	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	615161	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1011233	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1105152	usd
	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	16146	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	28632	usd
CY2024Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	58969	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	569938	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	162930	usd
CY2024Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	7806	usd
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5906	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	157024	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	201065672	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	201065672	shares
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent		usd
CY2024Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent		usd
CY2023Q3	us-gaap	Revenues Revenues		usd
	us-gaap	Revenues Revenues		usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue		usd
	us-gaap	Cost Of Revenue CostOfRevenue		usd
CY2023Q3	us-gaap	Gross Profit GrossProfit		usd
	us-gaap	Gross Profit GrossProfit		usd
CY2023Q3	us-gaap	Salaries And Wages SalariesAndWages		usd
	us-gaap	Salaries And Wages SalariesAndWages		usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense		usd
CY2024Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
	us-gaap	Share Based Compensation ShareBasedCompensation		usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		usd
	MDWK	Imputed Interest ImputedInterest		usd
	us-gaap	Interest Income Other InterestIncomeOther		usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense		usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories		usd
	MDWK	Increase Decrease In Right Of Use Assets IncreaseDecreaseInRightOfUseAssets		usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue		usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities		usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability		usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable		usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt		usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	MDWK	Property And Equipment Acquired With Notes Payable PropertyAndEquipmentAcquiredWithNotesPayable		usd
	MDWK	Note Receivable Issued For Asset Sale NoteReceivableIssuedForAssetSale		usd
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted		shares
	MDWK	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantsInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations		shares
	MDWK	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeited In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitedInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 20125
	dei	Entity Address City Or Town EntityAddressCityOrTown	Green Cove
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	32043
	dei	City Area Code CityAreaCode	(252)
	dei	Local Phone Number LocalPhoneNumber	501-0019
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	203744872	shares
CY2024Q3	us-gaap	Cash Cash	62478	usd
CY2023Q4	us-gaap	Cash Cash	115111	usd
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	16010	usd
CY2024Q3	us-gaap	Goodwill Goodwill	466648	usd
CY2023Q4	us-gaap	Goodwill Goodwill	466648	usd
CY2024Q3	us-gaap	Assets Assets	3294954	usd
CY2023Q4	us-gaap	Assets Assets	3233068	usd
CY2024Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	760558	usd
CY2023Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	668748	usd
CY2024Q3	us-gaap	Notes Payable Current NotesPayableCurrent	264967	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	96404	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	52779	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	316519	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	249175	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	1342044	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1067106	usd
CY2024Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	260994	usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	92830	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	786179	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	912915	usd
CY2024Q3	us-gaap	Liabilities Liabilities	2389217	usd
CY2023Q4	us-gaap	Liabilities Liabilities	2072851	usd
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	8957500	shares
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	8957500	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	8957500	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	8957500	shares
CY2024Q3	us-gaap	Preferred Stock Value PreferredStockValue	8958	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	8958	usd
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	202044872	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	202044872	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	198724868	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	198724868	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	202045	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	198725	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2178602	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	1691922	usd
CY2024Q3	MDWK	Subscription Payable SubscriptionPayable	165000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-739388	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1160217	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3233068	usd
CY2024Q3	us-gaap	Revenues Revenues	1058707	usd
	us-gaap	Revenues Revenues	2015261	usd
CY2024Q3	us-gaap	Cost Of Revenue CostOfRevenue	325839	usd
	us-gaap	Cost Of Revenue CostOfRevenue	1059088	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	732868	usd
	us-gaap	Gross Profit GrossProfit	956173	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	494821	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	128496	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1539442	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	234023	usd
CY2024Q3	us-gaap	Salaries And Wages SalariesAndWages	16148	usd
	us-gaap	Salaries And Wages SalariesAndWages	48443	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	636	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	212063	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	636	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	129132	usd
	us-gaap	Operating Expenses OperatingExpenses	1799948	usd
	us-gaap	Operating Expenses OperatingExpenses	234659	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-129132	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-843775	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-234659	usd
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1900	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5700	usd
CY2023Q3	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	168855	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-54000	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	168855	usd
CY2023Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	4232	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	17405	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	9908	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	164623	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-65705	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	158947	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	35491	usd
	us-gaap	Net Income Loss NetIncomeLoss	-909480	usd
	us-gaap	Net Income Loss NetIncomeLoss	-75712	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.00
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.00
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	125643163	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	200470538	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	124077691	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	125643163	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	200470538	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	124077691	shares
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1160217	usd
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	390000	usd
CY2024Q1	MDWK	Stock Issued During Period Value Common Shares To Be Issued For Royalty Agreement StockIssuedDuringPeriodValueCommonSharesToBeIssuedForRoyaltyAgreement	15000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-302389	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	1262828	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-764115	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	498713	usd
CY2024Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	250000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	157024	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	905737	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-114967	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	85598	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-41451	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-70820	usd
CY2023Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	100000	usd
CY2023Q2	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	2838	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-69752	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-37734	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-37734	usd
CY2023Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	206751	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	2116	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	35491	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	35491	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	206624	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	206624	usd
	us-gaap	Net Income Loss NetIncomeLoss	-909480	usd
	us-gaap	Net Income Loss NetIncomeLoss	-75712	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	212063	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	636	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-54000	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	168855	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	15000	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	976	usd
	MDWK	Imputed Interest ImputedInterest	4954	usd
	us-gaap	Interest Income Other InterestIncomeOther	5700	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	103442	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	16146	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-12577	usd
	MDWK	Increase Decrease In Right Of Use Assets IncreaseDecreaseInRightOfUseAssets	-93919	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	95711	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-30676	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-52779	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	2838	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-59392	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-662693	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-266815	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6990	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	88000	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	19500	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	100000	usd
	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	75000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6990	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-82500	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	120500	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	143450	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	118748	usd
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	19449	usd
	MDWK	Proceeds From Subscription Agreements ProceedsFromSubscriptionAgreements	640000	usd
	MDWK	Proceeds From Subscription Agreements ProceedsFromSubscriptionAgreements	392349	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	617050	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	491648	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-52633	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	142333	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	115111	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	23715	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	62478	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	166048	usd
	MDWK	Property And Equipment Acquired With Notes Payable PropertyAndEquipmentAcquiredWithNotesPayable	444891	usd
	MDWK	Note Receivable Issued For Asset Sale NoteReceivableIssuedForAssetSale	95000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_844_eus-gaap--UseOfEstimates_zGcRMWNxq9l1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zw9oIlDhrZO4">Use of Estimates and Assumptions</span> - </b>The preparation of financial statements in accordance with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of expenses during the reporting period. Actual results can, and in many cases will, differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	209200	usd
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	89202	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	106734	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	51967	usd
	us-gaap	Net Income Loss NetIncomeLoss	-909480	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-662693	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1648868	usd
CY2024Q3	us-gaap	Deferred Revenue DeferredRevenue	0	usd
CY2023Q4	us-gaap	Deferred Revenue DeferredRevenue	52779	usd
CY2024Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2024Q3	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	0	usd
CY2024Q3	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	10282	usd
	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	19501	usd
CY2024Q3	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	57771	usd
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	78352	usd
CY2024Q3	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	130859	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	122855	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	188630	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	201207	usd
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	817252	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	507677	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	168733	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	10787	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	648519	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	496890	usd
CY2024Q3	us-gaap	Depreciation Depreciation	61071	usd
	us-gaap	Depreciation Depreciation	124892	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	619500	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	619500	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	46643	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	4339	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	572857	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	615161	usd
CY2024Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	14102	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	42304	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	636	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	636	usd
	us-gaap	Finite Lived Intangible Assets Cost Incurred To Renew Or Extend FiniteLivedIntangibleAssetsCostIncurredToRenewOrExtend	56432	usd
CY2024Q3	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P5Y
CY2023	us-gaap	Property Plant And Equipment Disposals PropertyPlantAndEquipmentDisposals	195000	usd
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	100000	usd
CY2023	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	95000	usd
CY2023Q4	us-gaap	Sale Leaseback Transaction Net Book Value SaleLeasebackTransactionNetBookValue	26145	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	168855	usd
CY2023	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2029-08-25
CY2023	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.08	pure
CY2024Q3	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	103233	usd
CY2024Q3	us-gaap	Interest Receivable InterestReceivable	5700	usd
CY2023Q4	us-gaap	Notes And Loans Receivable Net Current NotesAndLoansReceivableNetCurrent	97533	usd
CY2023Q4	us-gaap	Interest Receivable InterestReceivable	2533	usd
CY2024Q3	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	1058707	usd
CY2023Q3	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	473906	usd
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	2015261	usd
	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	1763910	usd
CY2024Q3	MDWK	Business Acquisition Pro Forma Operating Loss BusinessAcquisitionProFormaOperatingLoss	162930	usd
CY2023Q3	MDWK	Business Acquisition Pro Forma Operating Loss BusinessAcquisitionProFormaOperatingLoss	-552810	usd
	MDWK	Business Acquisition Pro Forma Operating Loss BusinessAcquisitionProFormaOperatingLoss	-843775	usd
	MDWK	Business Acquisition Pro Forma Operating Loss BusinessAcquisitionProFormaOperatingLoss	-1186139	usd
CY2024Q3	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-157024	usd
CY2023Q3	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	404301	usd
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	909480	usd
	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	1033728	usd
CY2024Q3	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	0.00
CY2024Q3	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	0.00
CY2023Q3	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-0.00
CY2023Q3	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	-0.00
	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-0.00
	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	-0.00
	us-gaap	Business Acquisition Pro Forma Earnings Per Share Basic BusinessAcquisitionProFormaEarningsPerShareBasic	-0.01
	us-gaap	Business Acquisition Pro Forma Earnings Per Share Diluted BusinessAcquisitionProFormaEarningsPerShareDiluted	-0.01
CY2024Q3	MDWK	Business Acquisition Pro Forma Weighted Average Common Shares Outstanding Basic BusinessAcquisitionProFormaWeightedAverageCommonSharesOutstandingBasic	201065672	shares
CY2024Q3	MDWK	Business Acquisition Pro Forma Weighted Average Common Shares Outstanding Diluted BusinessAcquisitionProFormaWeightedAverageCommonSharesOutstandingDiluted	201065672	shares
CY2023Q3	MDWK	Business Acquisition Pro Forma Weighted Average Common Shares Outstanding Basic BusinessAcquisitionProFormaWeightedAverageCommonSharesOutstandingBasic	193143163	shares
CY2023Q3	MDWK	Business Acquisition Pro Forma Weighted Average Common Shares Outstanding Diluted BusinessAcquisitionProFormaWeightedAverageCommonSharesOutstandingDiluted	193143163	shares
	MDWK	Business Acquisition Pro Forma Weighted Average Common Shares Outstanding Basic BusinessAcquisitionProFormaWeightedAverageCommonSharesOutstandingBasic	200470538	shares
	MDWK	Business Acquisition Pro Forma Weighted Average Common Shares Outstanding Diluted BusinessAcquisitionProFormaWeightedAverageCommonSharesOutstandingDiluted	200470538	shares
	MDWK	Business Acquisition Pro Forma Weighted Average Common Shares Outstanding Basic BusinessAcquisitionProFormaWeightedAverageCommonSharesOutstandingBasic	191577691	shares
	MDWK	Business Acquisition Pro Forma Weighted Average Common Shares Outstanding Diluted BusinessAcquisitionProFormaWeightedAverageCommonSharesOutstandingDiluted	191577691	shares
CY2024Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	383877	usd
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	88674	usd
CY2024Q3	MDWK	Advances Payable Current AdvancesPayableCurrent	0	usd
CY2023Q4	MDWK	Advances Payable Current AdvancesPayableCurrent	0	usd
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	19449	usd
CY2024Q3	us-gaap	Loans Payable LoansPayable	525961	usd
CY2023Q4	us-gaap	Loans Payable LoansPayable	189234	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	264967	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	96731	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	67898	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	51274	usd
CY2024Q3	MDWK	Long Term Debt Maturities Repayments Of Principal In Year Four And Thereafter LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFourAndThereafter	45091	usd
CY2024Q3	us-gaap	Long Term Debt LongTermDebt	525961	usd
CY2024Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	7806	usd
CY2023Q3	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	4232	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	17405	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	9908	usd
CY2024Q3	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	6454	usd
CY2023Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	0	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	202044872	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	198724868	shares
	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	4620004	shares
	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	640000	usd
CY2024Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	1000000	shares
	us-gaap	Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures	5231310	shares
	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	392349	usd
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	8957500	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	8957500	shares
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	8957500	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	8957500	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	17262656	shares
CY2023Q4	MDWK	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice	1.50
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	17262656	shares
CY2024Q3	MDWK	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingWeightedAverageExercisePrice	1.50
CY2024Q3	MDWK	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber	17262656	shares
CY2024Q3	MDWK	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableWeightedAverageExercisePrice	1.50
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P3Y10M24D
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedIntrinsicValue	0
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4650685	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.36
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4650685	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.36
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Period Increase Decrease ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease	4650685	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.36
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P9Y2M8D
CY2024Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1011233	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	1102698	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1105152	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	1162090	usd
CY2024Q3	us-gaap	Operating Lease Expense OperatingLeaseExpense	82597	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	231741	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Rolling Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths	160125	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Two LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo	314613	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Three LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree	219112	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Four LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour	176088	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Five LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive	182132	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Rolling Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive	283783	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1335853	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	233155	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	1102698	usd
CY2024Q3	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P2Y6M14D
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001493152-24-045414-index-headers.html	Edgar Link	pending
0001493152-24-045414-index.html	Edgar Link	pending
0001493152-24-045414.txt	Edgar Link	pending
0001493152-24-045414-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
mdwk-20240930.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
mdwk-20240930_cal.xml	Edgar Link	unprocessable
mdwk-20240930_def.xml	Edgar Link	unprocessable
mdwk-20240930_lab.xml	Edgar Link	unprocessable
mdwk-20240930_pre.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MDWK
MDWerks, Inc. Stock $mdwk

2024 Q4 Form 10-Q Financial Statement

#000149315224045414 Filed on November 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MDWK MDWerks, Inc. Stock $mdwk

2024 Q4 Form 10-Q Financial Statement

#000149315224045414 Filed on November 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MDWK
MDWerks, Inc. Stock $mdwk